Tetsu Oyama

698 total citations
19 papers, 575 citations indexed

About

Tetsu Oyama is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Tetsu Oyama has authored 19 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Rheumatology. Recurrent topics in Tetsu Oyama's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Antifungal resistance and susceptibility (3 papers). Tetsu Oyama is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Antifungal resistance and susceptibility (3 papers). Tetsu Oyama collaborates with scholars based in Japan. Tetsu Oyama's co-authors include Nobuoki Kohno, Akihito Yokoyama, Kunio Hiwada, Michio Yamakido, Hiroyuki Maeda, Keiko Hiyama, Mitoshi Akiyama, Yoshikazu Inoue, Yukikazu Awaya and Nobuoki Kohno and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and International Journal of Molecular Medicine.

In The Last Decade

Tetsu Oyama

17 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsu Oyama Japan 8 281 173 121 112 85 19 575
Shoichiro Irimajiri Japan 13 103 0.4× 300 1.7× 29 0.2× 136 1.2× 105 1.2× 51 642
Timo Örmälä Finland 11 388 1.4× 130 0.8× 26 0.2× 146 1.3× 121 1.4× 19 720
Toshio Ozaki Japan 12 346 1.2× 53 0.3× 28 0.2× 72 0.6× 78 0.9× 32 588
C. N. Nair India 14 102 0.4× 38 0.2× 92 0.8× 86 0.8× 76 0.9× 41 493
O Kuperman Israel 15 59 0.2× 110 0.6× 43 0.4× 97 0.9× 127 1.5× 46 675
Rui Toledo Barros Brazil 13 69 0.2× 206 1.2× 36 0.3× 90 0.8× 48 0.6× 38 667
Yutaro Shiota Japan 11 182 0.6× 61 0.4× 23 0.2× 36 0.3× 56 0.7× 38 351
I. J. Temperley Ireland 13 64 0.2× 78 0.5× 68 0.6× 122 1.1× 122 1.4× 56 766
Roger E Spitzer United States 15 87 0.3× 42 0.2× 45 0.4× 83 0.7× 69 0.8× 50 733
Reiji Fukano Japan 15 114 0.4× 25 0.1× 121 1.0× 87 0.8× 100 1.2× 59 671

Countries citing papers authored by Tetsu Oyama

Since Specialization
Citations

This map shows the geographic impact of Tetsu Oyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsu Oyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsu Oyama more than expected).

Fields of papers citing papers by Tetsu Oyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsu Oyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsu Oyama. The network helps show where Tetsu Oyama may publish in the future.

Co-authorship network of co-authors of Tetsu Oyama

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsu Oyama. A scholar is included among the top collaborators of Tetsu Oyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsu Oyama. Tetsu Oyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yoshitama, Tamami, Tetsu Oyama, Akira Sagawa, et al.. (2017). AB1187 Survey on generic drugs (GE) and bio-similar drugs (BIO-S) of patients with rheumatoid arthritis (RA) and their doctors - cohort study of the japanese clinician biologics research group. Annals of the Rheumatic Diseases. 76. 1471–1471. 1 indexed citations
2.
Oiwa, Hiroshi, et al.. (2017). P1_69 Interstitial Lung Disease as a Possible Etiology of ANCA-associated Vasculitis: A Case Report. Lara D. Veeken. 56(suppl_3). iii65–iii81.
3.
Kohno, Nobuoki, Keishi Kubo, Yoshikazu Inoue, Tetsu Oyama, & Aya Sakaguchi. (2007). Drug-induced Pneumonia. Nihon Naika Gakkai Zasshi. 96(6). 1168–1186.
4.
5.
Oyama, Tetsu, Nobuoki Kohno, Akihito Yokoyama, et al.. (1999). High serum KL-6 levels predict the deterioration of pulmonary function in patients with rheumatoid arthritis. 9(4). 373–380. 1 indexed citations
6.
Oyama, Tetsu, Nobuoki Kohno, Akihito Yokoyama, et al.. (1999). High serum KL-6 levels predict the deterioration of pulmonary function in patients with rheumatoid arthritis. 9(4). 373–380. 1 indexed citations
7.
Takasugi, Kiyoshi, et al.. (1998). Sequential observation of generalized joint-resorptive phenomena in systemic mutilating rheumatoid arthritis. 8(1). 37–50. 1 indexed citations
8.
Takasugi, Kiyoshi, et al.. (1998). Sequential observation of generalized joint-resorptive phenomena in systemic mutilating rheumatoid arthritis. 8(1). 37–50. 1 indexed citations
9.
Oyama, Tetsu, Nobuoki Kohno, Akihito Yokoyama, et al.. (1997). Detection of Interstitial Pneumonitis in Patients with Rheumatoid Arthritis by Measuring Circulating Levels of KL-6, a Human MUC1 Mucin. Lung. 175(6). 379–385. 51 indexed citations
10.
Okuda, Yasuyuki, et al.. (1997). Intractable diarrhoea associated with secondary amyloidosis in rheumatoid arthritis. Annals of the Rheumatic Diseases. 56(9). 535–541. 30 indexed citations
11.
Oyama, Tetsu, et al.. (1995). [Sleep apnea syndrome in rheumatoid arthritis (RA) patients complicated with cervical and temporomandibular lesions].. PubMed. 35(1). 3–8. 1 indexed citations
12.
Okuda, Yasuhito, et al.. (1995). [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].. PubMed. 35(4). 699–704. 6 indexed citations
13.
Okuda, Yasuhito, et al.. (1994). [Amyloidosis in rheumatoid arthritis--clinical study of 124 histologically proven cases].. PubMed. 34(6). 939–46. 27 indexed citations
14.
Kohno, Nobuoki, Yukikazu Awaya, Tetsu Oyama, et al.. (1993). KL-6, a Mucin-like Glycoprotein, in Bronchoalveolar Lavage Fluid from Patients with Interstitial Lung Disease. American Review of Respiratory Disease. 148(3). 637–642. 246 indexed citations
15.
Ishioka, Shinichi, et al.. (1992). [Bronchoalveolar lavage fluid findings in rheumatoid arthritis].. PubMed. 30(4). 614–8. 2 indexed citations
16.
Awaya, Yukikazu, Shinichi Ishioka, Soichiro Hozawa, et al.. (1991). Analyses of Broncho Alveolar Lav Age Fluid (BALF) in MRL-LPR/LPR Mice. Autoimmunity. 8(3). 183–186. 1 indexed citations
17.
Kohno, Nobuoki, Seishi Kyoizumi, Masaru Tanabe, et al.. (1989). Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay.. PubMed. 49(12). 3412–9. 22 indexed citations
18.
Hozawa, Soichiro, Shinichi Ishioka, Koichi Takahashi, et al.. (1988). Somatic Mutation in Peripheral Lymphocytes of Former Workers at the Okunojima Poison Gas Factory. Japanese Journal of Cancer Research. 79(12). 1276–1283. 28 indexed citations
19.
Kohno, Nobuoki, Mitoshi Akiyama, Seishi Kyoizumi, et al.. (1987). A novel method for screening monoclonal antibodies reacting with antigenic determinants on soluble antigens; a reversed indirect-enzyme linked immunosorbent assay (RI-ELISA).. PubMed. 36(4). 319–23. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoichiro Irimajiri Breakdown of academic impact, for papers by Timo Örmälä Breakdown of academic impact, for papers by Toshio Ozaki Breakdown of academic impact, for papers by C. N. Nair Breakdown of academic impact, for papers by O Kuperman Breakdown of academic impact, for papers by Rui Toledo Barros Breakdown of academic impact, for papers by Yutaro Shiota Breakdown of academic impact, for papers by I. J. Temperley Breakdown of academic impact, for papers by Roger E Spitzer Breakdown of academic impact, for papers by Reiji Fukano
Rankless by CCL
2026